LUYE PHARMA GROUP LIMITED financial statements, including revenue, expenses, profit, and loss
The total revenue of 2186 for the last semiannual is 3.50 B HKD, and it's 6.54% higher compared to the previous semiannual. The net income of H2 23 is 413.37 M HKD.